Monday, December 23, 2024
HomeTagsGBM

GBM

CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal

CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics